Search Result "lupus antico-agulant"
Lupus Nephritis: A Treatment Update
Journal: Current Clinical Pharmacology
Volume: 13 Issue: 1 Year: 2018 Page: 4-13
Author(s): Fahad Aziz,Kunal Chaudhary
Neuropsychiatric Systemic Lupus Erythematosus
Journal: Current Neuropharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 449-457
Author(s): Alexandra Popescu, Amy H. Kao
Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 1 Year: 2008 Page: 1261-1269
Author(s): Giovanni Sanna, Maria Laura Bertolaccini, Munther A. Khamashta
Antiphospholipid Syndrome: Characteristics and Obstetrical Management
Journal: Current Drug Targets
Volume: 6 Issue: 5 Year: 2005 Page: 593-605
Author(s): Tomizo Nishiguchi, Takao Kobayashi
The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 4 Year: 2010 Page: 437-449
Author(s): Armen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P. Mikhailidis, Tracey E. Toms, Karen M.J. Douglas, George D. Kitas
Heart Valve Lesions In The Antiphospholipid Syndrome
Journal: Current Rheumatology Reviews
Volume: 8 Issue: 3 Year: 2012 Page: 161-165
Author(s): Ricard Cervera,Gerard Espinosa
Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 3483-3486
Author(s): Alessandra Malato, Giorgia Saccullo, Alfonso Iorio, Walter Ageno, Sergio Siragusa
Catastrophic Antiphospholipid Syndrome - 20 Years Later
Journal: Current Rheumatology Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 73-80
Author(s):
Molecular Docking, DFT Studies and ADMET Simulations for Evaluating Already Approved FDA Drugs as Inhibitors for SARS-Cov-2 RNADependent Polymerase
Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 7 Year: 2021 Page: 674-685
Author(s): Manos C. Vlasiou,Kyriakos I. Ioannou,Kyriaki S. Pafiti
Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges
Journal: Current Drug Metabolism
Volume: 18 Issue: 7 Year: 2017 Page: 598-608
Author(s): Emmanuel J. Favaloro,Leonardo Pasalic,Jennifer Curnow,Giuseppe Lippi